ReviewFrontiers in microbiology2026
Advances in the evolution of antibiotic resistance risks in hospital wastewater and multibarrier control strategies.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since it is imbued with antibiotics, resistant bacteria, and their resistance genes, hospital waste has transformed post-medical "tail water" into a global epicenter of connected ecological and health emergencies. By considering a "gap identification, risk tracking, and barrier rebuilding" framework and integrating 10 years of worldwide evidence, we first reveal how four mutually reinforcing deficits: absent primary treatment units, static design, aging infrastructure, and a hollowed-out workforce-perpetually overload small-scale facilities, unleashing high loads of antibiotics and antibiotics resistance genes (ARGs). We then follow ng/L residues along the "outfall-sediment-zooplankton-fish" continuum, showing how horizontal gene transfer (HGT) and mutational evolution processes restructure microbial communities, suppress algal photosynthesis and fish reproduction, and ultimately amplify threats to biodiversity and human health throughout the food web. To address the paradox that treatment does not equate to safety, we advance a multibarrier portfolio: (i) implement proactive retrofitting of equipment to confer inherent operational flexibility; (ii) process-stage adsorption-biodegradation hybrids that curtail selective pressure; and (iii) a harmonized, end-line monitoring network coupled with bioindicators to pinpoint ARG hotspots. Complementary measures, including regional pooled maintenance, microcredential training, green finance incentives, and a global data-sharing platform, shift the governance paradigm from end-of-pipe removal to life-cycle risk management, offering a replicable, technoinstitutional roadmap to overcome the pollution-resistance feedback loop.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.